Navigation Links
PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
Date:8/30/2010

PRINCETON, N.J., Aug. 30 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of drug development services to the pharmaceutical, biotechnology, generic drug and medical device industries, announced today that Anthony Maida, PhD has joined the Company as Vice President, Clinical Research. Dr. Maida will be responsible for leading PharmaNet's oncology team.

"Anthony's experience spans the drug development process. He has a unique strength in his well balanced expertise across strategic, operational and financial aspects of the business," said Dr. Robert Reekie, Chief Operating Officer and Senior Executive Vice President, Late Stage Development. "We are pleased to have Anthony as part of our outstanding oncology team."

Dr. Maida has more than twenty years of experience providing strategic, operational, and financial expertise to pharmaceutical companies that are focused primarily in the area of oncology.  Most recently, he ran his own consulting firm providing both pharmaceutical product development and capital raising capabilities to pharmaceutical firms, working with venture capital funds and investment banks. Prior to joining the pharmaceutical industry, Dr. Maida worked for Lockheed Corporation in a number of key financial roles.

Dr. Maida earned Bachelor of Arts degrees from the University of Santa Clara and San Jose State University, a Masters of Business Administration degree from the University of Santa Clara, a Masters degree in Toxicology from San Jose State University and a PhD in Tumor Immunology, from the University of California, Davis.  

About PharmaNet Development Group, Inc. PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2300 employees in 33 countries and more than 38 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.  Contact: Anne-Marie HessPhone: (609) 951-6842E-mail: ahess@pharmanet.com
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer
2. SEC Closes Investigation of PharmaNet Development Group and Recommends No Action
3. Christopher Brennan Joins PharmaNet Development Group as General Counsel
4. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
5. PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
6. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
7. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
8. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
9. PharmaNet Development Group Agrees to be Acquired by JLL Partners
10. Cord Blood America CEO Updates Investors on Financial Developments and Stem Cell News in Interview
11. Torbjorn Bjerke Appointed as new CEO for Karolinska Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):